You are here

Pharmacokinetic parameters of Tilmicosin Phosphate in the body of healthy broiler chickens

The article presents the results of studies of the intake (oral administration), distribution and excretion of Tilmicosin Phosphate (active ingredient of the Tilmox 25%) from the body of healthy broiler chickens of the KOBB-500 cross. The rapid absorption of Tilmicosin Phosphate from the alimentary tract of the birds and its entry into the internal organs was established. The maximum content of Tilmicosin Phosphate was found in the lungs and liver. Only in 2 hours after the beginning of the Tilmox 25% solution application, which was 17.02 ± 0.24 and 12.78 ± 0.22 μg / g, its content in the kidneys after 26 hours was 8 25 ± 0.19 μg / g, pectoral and cardiac muscles after 52 hours - 6.19 ± 0.28 and 5.23 ± 0.39 μg / g, respectively. Consumption of Tilmox 25% solution by a healthy bird was not accompanied by the accumulation of Tilmicosin Phosphate (material accumulation), since its content in the internal organs and muscles of the bird did not depend on the duration of the drug use. During 96 hours of Tilmox 25% solution consumption by broiler chickens the maximum content of Tilmicosin Phosphate was detected in the lungs, which indicates its tissue tropism. The distribution of Tilmicosin Phosphate in maximum amounts to the lungs ("organ affinity" or "tissue tropism") is important when infectious agents are localization in the lungs of poultry, as well as for the treatment of patients with respiratory diseases of various etiology. The cessation of the use of Tilmox 25% was accompanied by a significant decrease in the content of its active substance, Tilmicosin Phosphate, in the organs under study. Twenty-four hours after the cessation of consumption the tilmox solution (120 hours of the experiment), the content of Tilmicosin Phosphate in the lungs was 1.9 times less, liver – 1.6 times, kidneys – 1.4 times, pectoral muscle - 1.7 times, cardiac muscle – 1.3 times less, compared with indicators on 96 hours of experiment. Five days after the cessation of feeding the tilmox solution to broiler chickens (216 hours of the experiment), the residual amounts of Tilmicosin Phosphate in the organs under study were: in the lungs – 1.20 ± 0.03 μg / g; liver – 1.01 ± 0.02; kidneys - 0.91 ± 0.03 μg / g. The lowest content of Tilmicosin Phosphate, during this period of research, was only in one of the three samples of the heart muscle – 0.02 μg / g, and it was not detected in the pectoral muscle.

Key words: Tilmox 25 %, organs, distribution, accumulation, excretion, pharmacokinetics.



  1. Creemer, L., Beier, R., Kjehl, D. (2003). Facile synthesis of tilmicosin and tylosin related haptens for use as protein conjugates. The journal of antibiotics. Vol. 56(5), pp. 481–487. DOI:10.7164/antibi otics.56.481
  2. Rasheed, M. A., Ashraf, M., Javeed, A. (2018). Toxicological evaluation of tilmicosin after intramuscular injection in broiler chicken. The Journal of Animal & Plant Sciences. Vol. 28(6), pp. 1678–1686. Available
  3. Elkomy, A., Eltanany, N., Aboubakr, M., Mohamed, Z., Elbadawy, M. (2018). Pharmacokinetics and Tissue Residues of Tilmicosin in Normal and Experimentally Mycoplasma Gallisepticum-Infected Broiler Chickens. Benha veterinary medical journal, [Special issue for the 6 th scientific international conference]. Vol. 34, no. 3, pp. 188–205. DOI:10.21608/BVMJ.2018.44745
  4. Debono, M., Willard, K.E., Kirst, H.A., Wind, J.A., Crouse, G.D., Tao, E.V., Vicenzi, J.T., Counter, F.T., Ott, J.L., Ose, E.E. (1989). Synthesis and antimicrobial evaluation of 20-deoxo-20-(3,5-dimethylpiperidin-1) desmycosin (tilmicosin, EL-870) and related cyclic amino derivatives. J. Antibiot. (Tokyo). Vol. 42 (8), pp. 1253–1267. DOI:10.7164/antibiotics.42.1253
  5. Dimitrova, D., Georgiev, K., Tsoneva, D. (2012). Pharmacokinetics of tilmicosin in broiler chickens after single oral application. Institute of Mountain Animal Stockbreeding and Agriculture, Troyan Bulgaria. Vol. 15, no. (1), pp. 1–12. Available recordID=BG2012000468
  6. Xu, S., Dieter, A. (2008). Tilmicosin. Addendum to the monographs prepared by the 47th meeting of the Committee. FAO Food and Nutrition Paper. Vol. 41(9), pp. 2–37. Available at:fileadmin/ user_upload/vetdrug/docs/6-2009-tilmicosin.pdf
  7. Dimitrova, D., Petkov, P., Tsoneva, D. (2012). Pharmacokinetics of tilmicosin in calves after single subcutaneous application. Agri. Sci. & technol. Vol. 4 (3), pp. 211–214. Available at:resear
  8. Dingwell, R.T., Leslie, K.E., Duffield, T.F., Schukken, Y.H., DesCoteaux, L., Keefe, G.P., Kelton, D.F., Lissemore, K.D., Shewfelt, W., Dick, P., Bagg, R. (2003). Efficacy of intramammary tilmicosin and risk factors for cure of Pharmacokinetics and Tissue Residues of Tilmicosin in Normal and Experimentally Mycoplasma Gallisepticum-Infected Broiler Chickens Staphylococcus aureus infection in the dry period. J. Dairy Sci. Vol. 86(1), pp. 159–168. DOI: 10.3168/jds.S0022-0302(03)73596-6.
  9. Elbadawy, M., Aboubakr, M. (2017). Pharmacokinetics, tissue residues of tilmicosin phosphate (tilmicoral®) and it's in vitro and in vivo evaluation for the control of Mycoplasma gallisepticum infection in broiler chickens. Int. J. Pharmacol. Toxicol. Vol. 5 (1), pp. 11–16. DOI:10.14419/ijpt. v5i1.7084
  10. Xiong, J., Zhu, Q., Yang, S., Zhao, Y., Cui, L., Zhuang, F., Qui, Y., Cao, J. (2019). Comparison of pharmacokinetics of tilmicosin in healthy pigs and pigs experimentally infected with Actinobacillus pleuropneumoniae. New Zealand Veterinary Journal. Vol. 67(5), pp. 257–263. DOI: 10.1080/0048 0169.2019.1633434
  11. Huang, Z., Wu, Y., Zhou, Z., Xia, X., Cu, X., Cai, Q., Ding, H. (2019). Pharmacokinetic and Pharmacodynamic Integration and Resistance Analysis of Tilmicosin Against Mycoplasma gallisepticum in an In Vitro Dynamic Model. Experimental pharmacology and drug discovery. Vol. 492, pp. 187–197. DOI:10.3389/fphar.2019.00670
  12. Elsayed, M., Elkomy, A., Aboubakr, M., Morad, M. (2014). Tissue residues, hematological and biochemical effects of tilmicosin in broiler chicken. Vet. Med. Int. pp. 1–6. DOI:10.1155/ 2014/502872
  13. Jordan, F.T.W., Forrester, C.A., Hodge, A., Reeve-Johonson, L.G. (1999). The comparison of an aqueous preparation of tilmicosin with tylosin in the treatment of Mycoplasma gallisepticum infection of turkey poults. Avian Dis. Vol. 43(3), pp. 521–525. PMID:10494422
  14. Abu-Basha, E., Idkaidek, N., Al-Shunnaq, A. (2007). Pharmacokinetics of tilmicosin (provitil powder and pulmotil liquid ac) oral formulations in chickens. Veterinary Research Communications. Vol. 31(4), pp. 477–485. DOI:10.1007/s11259-006-3543-6
  15. Attia, T., Latif, A., El-Hanbally, S., El-Gendy, H., El Gendy, H (2018). Dispositions kinetics, in vitro plasma protein binding, and tissue residues of tilmicosin in healthy and experimentally (CRD) infected broiler chickens. International Journal of Basic & Clinical Pharmacology. Vol. 7(11), pp. 2201–2208. DOI:10.18203/2319-2003.ijbcp20184328
  16. Кеles, O., Bakirel, T., Sener, S. (2001). Pharmacokinetics and tissue levels of tilmicosin in fows. Tur J Vete Ani Sci. Turkicsh Journal of Veterinary and Animals Sciences. Vol. 25, pp. 629–634. Available
  17. El-Ela, F.I.A., El-Banna, H.A., El-Deen, M.B., El-Gendy, A.A., Tohamy, M.A. (2015). Pharmacokinetics of Tilvasolin alone or in combination with Vitamin E in broiler chickens. Asian Jornal of Animal and Veterinari Advances. Vol. 10(10), pp. 556–566. DOI:10.3923/ajava.2015.556.566
  18. Keles, O., Bakirel, T., Sener, S. (2001). Pharmacokinetics and tissue levels of tilmicosin in fowls. Turk. J. Vet. Anim. Sci. Vol. 25(4), pp. 629–634. PMID: 8790882
  19. Kleven, S.H. (1990). Summary of discussion of avian mycoplasma team, IRPCM, IOM. Avian Pathol. Vol. 19, pp. 795–800. PMID: 9454912
  20. Horie, M., Takegami, H., Toya, K., Nakazawa, H. (2003). Determination of macrolide antibiotics in meat and fish by liquid chromatography–electrospray mass spectrometry. Analytica Chimica Acta. Vol. 44(3), pp. 150–154. DOI:10.3358/shokueishi.44.150.
PDF icon dukhnitsky_2_2021.pdf596.27 KB